Home Applications 216158 Application 216158
Type NDA
Sponsor BRISTOL-MYERS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 COBENFY TROSPIUM CHLORIDE; XANOMELINE TARTRATE CAPSULE;ORAL 20MG;EQ 50MG BASE Yes Yes 002 COBENFY TROSPIUM CHLORIDE; XANOMELINE TARTRATE CAPSULE;ORAL 20MG;EQ 100MG BASE Yes No 003 COBENFY TROSPIUM CHLORIDE; XANOMELINE TARTRATE CAPSULE;ORAL 30MG;EQ 125MG BASE Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N216158-001 COBENFY TROSPIUM CHLORIDE; XANOMELINE TARTRATE 20MG;EQ 50MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 N216158-002 COBENFY TROSPIUM CHLORIDE; XANOMELINE TARTRATE 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 N216158-003 COBENFY TROSPIUM CHLORIDE; XANOMELINE TARTRATE 30MG;EQ 125MG BASE CAPSULE / ORAL RLD 2024-09-26
Orange Book patents# Current patent rows page 1 of 1 · 33 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N216158-001 NCE 2029-09-26 N216158-002 NCE 2029-09-26 N216158-003 NCE 2029-09-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD 2024-09-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD 2024-09-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD 2024-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD 2024-09-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD 2024-09-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD 2024-09-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD 2024-09-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD 2024-09-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD 2024-09-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N216158-001 COBENFY 20MG;EQ 50MG BASE CAPSULE / ORAL RLD, RS 2024-09-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N216158-002 COBENFY 20MG;EQ 100MG BASE CAPSULE / ORAL RLD 2024-09-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N216158-003 COBENFY 30MG;EQ 125MG BASE CAPSULE / ORAL RLD 2024-09-26 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 7 · 273 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N216158-001 10238643 2030-07-21 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 10265311 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 10369143 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 10369144 2030-07-21 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 10695339 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 10925832 2039-09-27 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 10933020 2039-09-27 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 11452692 2039-09-27 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 11471413 2039-09-27 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-001 11890378 2039-09-27 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 10238643 2030-07-21 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 10265311 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 10369143 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 10369144 2030-07-21 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 10695339 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 10925832 2039-09-27 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 10933020 2039-09-27 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 11452692 2039-09-27 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 11471413 2039-09-27 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-002 11890378 2039-09-27 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 10238643 2030-07-21 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 10265311 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 10369143 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 10369144 2030-07-21 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 10695339 2030-07-21 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 10925832 2039-09-27 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 10933020 2039-09-27 U-3513 Drug product 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 11452692 2039-09-27 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 11471413 2039-09-27 U-3513 2024-10-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216158-003 11890378 2039-09-27 U-3513 Drug product 2024-10-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 10238643 2030-07-21 Drug product 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 10265311 2030-07-21 U-3513 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 10369143 2030-07-21 U-3513 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 10369144 2030-07-21 U-3513 Drug product 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 10695339 2030-07-21 U-3513 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 10925832 2039-09-27 Drug product 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 10933020 2039-09-27 U-3513 Drug product 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 11452692 2039-09-27 U-3513 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 11471413 2039-09-27 U-3513 2024-10-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216158-001 11890378 2039-09-27 U-3513 Drug product 2024-10-25 31067a03dcf5…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Cobenfy XANOMELINE AND TROSPIUM CHLORIDE E.R. Squibb & Sons, L.L.C. 8f0e73bf-6025-44f6-ab64-0983322de0df 2026-01-16 Warnings, Adverse reactions Exact identifier application applno (NDA): 216158 application number: NDA216158
Documents# Document, Submission type, Date table Document Submission type Date 80168 ORIG 2024-11-05 79755 ORIG 2024-09-27 79752 ORIG 2024-09-27